![Pharmaceuticals | Free Full-Text | Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades | HTML Pharmaceuticals | Free Full-Text | Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades | HTML](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-00710/article_deploy/html/images/pharmaceuticals-14-00710-g017-550.jpg)
Pharmaceuticals | Free Full-Text | Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades | HTML
![Celcuity Announces Clinical Trial Collaboration with Massachusetts General Hospital and Puma Biotechnology Celcuity Announces Clinical Trial Collaboration with Massachusetts General Hospital and Puma Biotechnology](https://storage.googleapis.com/accesswire/logos/subaccounts/18463.jpg?v=0)
Celcuity Announces Clinical Trial Collaboration with Massachusetts General Hospital and Puma Biotechnology
![Predicting Solubility of Newly-Approved Drugs (2016–2020) with a Simple ABSOLV and GSE(Flexible-Acceptor) Consensus Model Outperforming Random Forest Regression | SpringerLink Predicting Solubility of Newly-Approved Drugs (2016–2020) with a Simple ABSOLV and GSE(Flexible-Acceptor) Consensus Model Outperforming Random Forest Regression | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10953-022-01141-7/MediaObjects/10953_2022_1141_Fig3_HTML.png)